Underweight GS with 25-35% trim into relief toward $951-$972; $951 daily close stop; Q3 earnings as binary catalyst
Underweight rating is dispositive based on three-analyst convergence on directional call: technical breakdown confirmed (200 SMA broken at $951, MACD at -26 with widening histogram, eight consecutive weeks of lower highs/lows, price below all major moving averages), cyclical peak earnings thesis validated (Q2 2026 likely cyclical high-water mark, Q3 base of only $4.10 EPS requiring triple-digit YoY growth, DB flat-to-down Q3 IB guidance corroborating), and deteriorating macro regime creating second-derivative risk to $539B trading book. Probability-weighted EV of $863 vs $935 shows -7.7% negative skew. The 25-35% trim captures the 9/22 baseline + 9/23 escalation + 9/24 buyback-floor weighting, rejecting the aggressive analyst's 60-75% trim (violates binding prior lessons on structural defense for high-quality compounders with active buyback programs) and explicit SELL/full exit (preserves franchise optionality on Palmer Square/Cyera compounding and OpenAI IPO optionality). Execution prioritized into relief pushes toward $951-$972 zone rather than at market, treating any bounces as distribution opportunities until the $951 reclaim signal prints.
| Position | Action |
|---|---|
| Default tactical position | Trim 25-35% of GS target allocation executed across 2-3 trading sessions |
| Relief rally materializes toward 200 SMA zone | Scale trim into $951-$972 zone using VWMA/lower Bollinger band as exit liquidity |
| No relief within 2-3 session window | Scale out at market with pre-committed discipline |
| Residual exposure is material | Small protective-put overlay acceptable as complement to position sizing (does not replace sizing) |
| Daily close below $951 on >3.5M shares with MACD histogram turning positive | Re-engagement signal to consider adding back trimmed exposure |
Goldman Sachs at $935 with a 12.7x forward P/E, 92% YoY EPS doubling, and an $11.7B PE fundraise closing represents a classic value-growth mispricing being punished for macro rate sensitivity rather than franchise deterioration—the earnings engine is accelerating, the technical setup shows capitulation, and the macro regime of higher rates and steeper curves is actually bullish for FICC and NII revenue.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 954.00 | bearish |
| close_50_sma | 1017.46 | bearish |
| close_200_sma | 951.43 | bearish |
| rsi | 36.46 | neutral |
| macd | -26.07 (signal -19.92, histogram -6.15) | bearish |
| boll_ub | 1070.77 | bearish |
| atr | 26.59 | neutral |
| vwma | 964.80 | bearish |
Support: 915 · 922 · 904 | Resistance: 951.43 · 954 · 1000 · 1017.46 · 1070.77
GS technical analysis dated September 25, 2026 shows a sharp pullback from the July 15, 2026 high of 1148.37, with the stock carving out a topping/reversal pattern characterized by lower highs (1148.37 → 1093.78 → 1053.72 → 1038.61 → 959.39) and lower lows (972.93 → 922.00 → 914.68 → 915.30). The most critical development was the September 14, 2026 breakdown below the 200 SMA at 951.43 on a -3.9% day, followed by a crash low of 922.00 intraday on September 16. Volume has been skewed to the sell side throughout September, with notable volume spikes of 3,546,200 shares on September 16 and 3,980,200 shares on September 18, while VWMA at 964.80 remains above price action. Momentum remains bearish with MACD at -26.07 (signal -19.92, histogram -6.15) showing widening histogram on the bearish side, though RSI touched 30.72 on September 16 (approaching oversold) and has recovered to 36.46. ATR compression from 35-38 down to 26.59 suggests volatility expansion is subsiding. The immediate resistance zone is 950-955 (200 SMA and 10 EMA overlap), with stronger resistance at 1000 and 1017 (50 SMA), while support sits at 915-922 and critically at 904 (Bollinger lower band). Outlook is bearish short-term and neutral medium-term; a bullish reversal would require daily close above 951.43 on expanding volume with RSI crossing above 50 and MACD histogram turning positive. Rating: HOLD.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Weekly close below $880 on expansion volume
Then: Full exit escalation
The $11.7B PE fundraise creates a multi-year fee annuity at zero capital cost
↩ rebuts: “Bear concern that AWM fees will stall”
EV: +17 (200 SMA reclaim at $951, near-term); +85 (50 SMA at $1,017, intermediate-term) · concedes: The trend has rolled over and price is below the 200 SMA; MACD is deeply negative with volume skewed to sellers; Deutsche Bank's Q3 IB guidance is a legitimate data point for sector headwinds; A 204% three-year run creates psychological overhead and potential for mean-reversion; The stock is 19% off its highs, suggesting some of the easy money has been made; Q3 EPS estimate of $22+ requires backlog conversion to proceed on schedule
The risk/reward at $935 is asymmetric to the downside; the technical setup is broken, the macro is hostile to multiples, peer signals are deteriorating, and GS's own asset management team is signaling caution on AI credit risk—meaning the earnings surge is a cyclical peak, not a new secular baseline.
EV: -$72 per share (-7.7%) · concedes: Q2 2026 earnings print was genuinely strong with $20.98 EPS and 16.9% ROE; A 14x P/E on double-digit ROE is not expensive in absolute terms; RSI at 36 does indicate oversold conditions that could produce a bounce; The $11.7B PE fundraise demonstrates GS's alternatives franchise strength; FICC diversification does provide some buffer against single-sector stress; A relief rally to $1,000-1,017 is possible even in a downtrend
→ vs conservative: Forward P/E 12.7x, ROE 16.9%, and EPS doubling YoY are cyclical peak earnings, not a franchise growing into a cheap multiple — Q2 2026 EPS of $20.98 laps a depressed Q2 2025 base of $10.91, and Q3 2025 was only $4.10; calling a $539B trading book and $475B debt 'a one-quarter FICC tailwind' is intellectual malpractice when a 50bp move becomes forced-mark-to-market
→ vs neutral: RSI-36 and ATR compression signal exhaustion traps, not buy points — 200 SMA broke September 14th, MACD at -6.15 and widening, 8 consecutive weeks of lower highs and lower lows is institutional distribution; waiting for Q3 print means Q4 damage is already done; $951 invalidation level and technicals reading 2/10 override sentiment reading 6/10
→ vs neutral: Sentiment reading 6.0/10 with zero retail confirmation and $11.7B PE fundraising represents priced-in bullishness; the bearish macro regime (90% Fed hike odds, 10Y at 2007 highs, GS AM underweight AI borrowers) is not priced in — when technicals read 2/10 and sentiment reads 6/10, go with technicals
Market Cap
$272.4B
P/E (TTM)
14.45x
Forward P/E
12.72x
P/B
2.58x
PEG
1.14
Dividend Yield
2.17%
Revenue TTM
$67.6B
Net Income TTM
$20.0B
Profit Margin
31.0%
Operating Margin
42.2%
ROE
16.9%
ROA
1.07%
Total Assets
$2,127.7B
Stockholders' Equity
$122.7B
Total Debt
$475.0B
Net Debt
$285.7B
Cash & Equivalents
$187.3B
Tangible Book Value
$100.4B
Common Shares Outstanding
291.4M
EPS (TTM)
$64.72
Forward EPS
$73.55
Book Value/Share
$362.05
52-Week High
$1,153.99
52-Week Low
$740.01
50-Day MA
$1,023.91
200-Day MA
$958.98
Beta
1.283
Current Ratio
1.56
Q2 2026 Total Revenue
$20,338M
Q2 2026 Net Income
$6,628M
Q2 2026 Diluted EPS
$20.98
Q2 2026 Pretax Margin
42.1%
Net Interest Income Q2 2026
$3.95B
Net Interest Income Q2 2025
$3.10B
Total Assets Jun 2025
$1,785.0B
Implied Stock Price
~$935.50
Strengths
Concerns
Goldman Sachs demonstrates a clear earnings acceleration phase in 2026, with Q2 2026 revenue up 39.5% YoY and EPS nearly doubling year-over-year, driven by a Capital Markets recovery including M&A and IPO rebound activity. The valuation remains attractive at a TTM P/E of 14.45x and forward P/E of 12.72x, supporting a PEG ratio near 1.0, while the firm maintains sector-leading profitability with a 16.9% ROE and 42.2% operating margin. The company is aggressively returning capital to shareholders through ~$20B+ annualized distributions (dividends and buybacks) and continues to grow tangible book value despite buying back shares above per-share book value. The primary risk is cyclical reversal in capital markets activity, though the current trajectory supports a constructive fundamental view.
Macro: Bond-market dislocation with 10Y Treasury at highest since 2007 (>5.0%) and 30Y at highest since 2004; mortgage rates creeping toward 7.5%. Polymarket pricing hawkish Fed repricing: 97% probability of no rate cuts in 2026, 90% probability of another hike, 39% probability of 3 hikes (+18.1pp WoW). US recession odds remain low at 10% for end-2026. Trump–Xi summit (Oct 8 resolution) acting as near-term risk-on catalyst for tech. Hormuz/Iran risk keeping oil/geopolitical bid in market.